Filing Flows › Technology › BioScience Health Innovations (BHIC)
BioScience Health Innovations (BHIC) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 7, 2026 · BioScience Health Innovations (BHIC) Q2 2026 earnings results →
Q2 2026 Revenue down 41% year over year to $1.0M · 18¢ of every $1 of revenue lost · operating margin -21.0%
BioScience Health Innovations made $1.0M in Q2 2026 (-41% Y/Y). Operating margin -21.0%, net loss $186K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 7, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $1.0M in Q2 2026, down 41% year over year and up 38% from the previous quarter.
Gross margin was 63.6%, up 2.5 points from Q2 2025. Operating costs exceeded revenue by $218K, an operating margin of -21.0%. Operating expenses grew 42% against a revenue fall of 41%. The fastest-growing cost line was Research & development (+664%). The quarter ended with a net loss of $186K, narrower than the previous quarter's $230K loss.
Operating cash flow was −$542K. Working capital and other items used $356K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 7, 2026 | $1.0M | -41% | -21.0% | −$186K | −$542K |
| Q1 2026 | 10-Q | May 11, 2026 | $751K | -39% | -30.6% | −$230K | −$552K |
| Q4 2025 | 10-K | Mar 30, 2026 | $1.6M | +158% | -10.0% | −$234K | −$101K |
| Q3 2025 | 10-Q | Oct 27, 2025 | $1.1M | +98% | -0.8% | −$9K | −$340K |
| Q2 2025 | 10-Q | Aug 7, 2025 | $1.8M | +358% | 26.0% | $458K | $285K |
| Q1 2025 | 10-Q | May 8, 2025 | $1.2M | +342% | 34.8% | $427K | $328K |
| Q4 2024 | 10-K | Mar 13, 2025 | $610K | +101% | 1.6% | $10K | −$50K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About BioScience Health Innovations
This annual report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our ability to locate and acquire an operating business, the status of our current acquisition opportunity and the resources and efforts we intend to dedicate to such an endeavor, our development of a viable business plan and our ability to locate sources of capital necessary to meet our business needs and objectives. All statements other than statements of historical facts contained in this Report, including statements that relate to our future financial performance, liquidity, business strategy and plans and objectives of management for future operations, are forward-looking statements.
In its own words, from its 10-K, filed Mar 30, 2026.
BioScience Health Innovations against its Services-Computer Processing & Data Preparation peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -41% against the peers' median +6%. Operating margin: -21.0% against the peers' median 11.8%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| BHIC BioScience Health Innovations | Q2 2026 | $1.0M | -41% | -21.0% |
| ADP Automatic Data Processing | Q1 FY27 | $5.5B | +6% | 23.9% |
| DXC DXC Technology | Q2 FY27 | $3.0B | -4% | 6.2% |
| WDAY Workday | Q2 FY27 | $2.6B | +13% | 11.8% |
| TOST Toast | Q3 2026 | $2.0B | +21% | 8.3% |
| RDDT Reddit | Q3 2026 | $895M | +53% | 29.2% |
| VRSK Verisk Analytics | Q3 2026 | $809M | +5% | 45.2% |
| RNG RingCentral | Q3 2026 | $676M | +6% | 8.0% |
| PLTK Playtika Holding | Q3 2026 | $674M | -0.1% | 17.2% |
Source: BioScience Health Innovations 10-Q on SEC EDGAR · CIK 1784440 · Services-Computer Processing & Data Preparation
More on BHIC
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results